Application 209415
- Type
- ANDA
- Sponsor
- KADMON PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRIENTINE HYDROCHLORIDE | TRIENTINE HYDROCHLORIDE | CAPSULE;ORAL | 250MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66435-700 | Trientine Hydrochloride | Trientine Hydrochloride | Kadmon Pharmaceuticals, LLC | ANDA | Current |
| 66435-700 | Trientine Hydrochloride | Trientine Hydrochloride | Kadmon Pharmaceuticals, LLC | ANDA | Current |
| 66435-700 | Trientine Hydrochloride | Trientine Hydrochloride | Kadmon Pharmaceuticals, LLC | ANDA | Current |